Rubric Capital Management LP Mereo Biopharma Group PLC Transaction History

Rubric Capital Management LP

$3.38 Billion
Q2 2024

A detailed history of Rubric Capital Management LP transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Rubric Capital Management LP holds 15,307,347 shares of MREO stock, worth $62.8 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares

15,307,347

Previous 13,552,997 12.94%

Holding current value

$62.8 Million

Previous $44.7 Million 23.21%

% of portfolio

1.63%

Previous 1.52%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.58 - $4.25 $4.53 Million - $7.46 Million	1,754,350 Added 12.94%	15,307,347 $55.1 Million
Q4 2023 Feb 13, 2024	BUY	$1.19 - $2.42 $2.3 Million - $4.69 Million	1,936,877 Added 16.67%	13,552,997 $31.3 Million
Q2 2023 Aug 11, 2023	BUY	$0.79 - $1.43 $987,500 - $1.79 Million	1,250,000 Added 12.06%	11,616,120 $15.3 Million
Q3 2022 Nov 14, 2022	SELL	$0.82 - $1.73 $5.24 Million - $11.1 Million	-6,390,000 Reduced 38.14%	10,366,120 $8.93 Million
Q2 2022 Aug 15, 2022	BUY	$0.33 - $1.69 $579,519 - $2.97 Million	1,756,120 Added 11.71%	16,756,120 $18.8 Million
Q1 2022 May 13, 2022	BUY	$1.04 - $1.7 $88,975 - $145,440	85,553 Added 0.57%	15,000,000 $16.8 Million
Q4 2021 Feb 14, 2022	BUY	$1.51 - $2.59 $5.46 Million - $9.36 Million	3,614,447 Added 31.99%	14,914,447 $23.9 Million
Q3 2021 Nov 12, 2021	BUY	$2.2 - $3.17 $12.4 Million - $17.9 Million	5,639,392 Added 99.63%	11,300,000 $27.3 Million
Q2 2021 Aug 13, 2021	BUY	$2.94 - $4.08 $8.07 Million - $11.2 Million	2,745,747 Added 94.2%	5,660,608 $17.9 Million
Q1 2021 May 14, 2021	BUY	$2.6 - $4.43 $2.76 Million - $4.7 Million	1,061,444 Added 57.27%	2,914,861 $9.82 Million
Q4 2020 Feb 16, 2021	BUY	$1.95 - $3.6 $3.61 Million - $6.67 Million	1,853,417 New	1,853,417 $6.64 Million

Others Institutions Holding MREO

# of Institutions

Shares Held

102M

Call Options Held

121K

Put Options Held

208K

View Full List

About Mereo Biopharma Group plc

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $512M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

More about MREO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Account

Rubric Capital Management LP Mereo Biopharma Group PLC Transaction History